Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital‐based case‐control study and a population‐based cohort study
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Objectives: This study aimed to investigate the association between proton pump inhibitor (PPI) use and risk of sensorineural hearing loss (SNHL) or tinnitus in patients with type 2 diabetes using hospital‐ and population‐based data. Methods: For the case‐control study using the Asan Biomedical Research Environment database, the characteristics between cases and sex‐, age‐ and index‐year‐matched controls were compared by the chi‐squared test. Conditional logistic regression was used to estimate the odds ratios (ORs). For the cohort study using the Korean National Health Insurance Service – National Sample Cohort, the hazard ratios (HRs) for SNHL or tinnitus associated with PPI use were analysed by the Cox proportional hazard regression model. Results: The case‐control study included 1379 cases and 5512 matched controls. After adjustment, PPI use was associated with an increased risk of SNHL or tinnitus (OR 1.61, 95% confidence interval [CI] 1.30‐1.99). The ORs were higher for current or recent use of PPI and high average daily dose. In the cohort study including 17 233 pairs of PPI users and nonusers after propensity score matching, the risk of SNHL or tinnitus increased in PPI users compared with nonusers (HR 1.50, 95% CI 1.40‐1.61). In the stratified analyses, risks remained significant and the magnitude of association was relatively high in those of younger age, patients without gastroesophageal reflux disease and patients not receiving histamine 2 receptor blockers. Conclusions: Our study suggests that PPI use is associated with an increased risk of SNHL or tinnitus. Given the widespread use of PPIs, the potential ototoxic effects of PPIs remain an important concern.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering PPI can affect cardiovascular system, PPI may affect the circulation defect of the cochlea and lead to tinnitus onset29,30.”
From Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study (2024) · cites this paper as [29]
In the citing paper
“Although the mechanism is still unknown, the possible mechanism is that PPI may directly act to inner ear physiology by inhibiting H, K-ATPase in the lateral wall of cochlear29.”
From Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study (2024) · cites this paper as [29]
In the citing paper
“Our result is in line with previous study showing the PPI medication is associated with tinnitus onset in type 2 diabetes patients29.”
From Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study (2024) · cites this paper as [29]
Citations
Cites
Cohort Profile: The National Health Insurance Service–National Sample Cohort (NHIS-NSC), South Korea
Lee, J., Lee, J. S., Park, S.-H., Shin, S. A., & Kim, K. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyv319 · Cited by 1,469
Baguley, D., McFerran, D., & Hall, D. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60142-7 · Cited by 1,245
Tinnitus: causes and clinical management
Langguth, B., Kreuzer, P. M., Kleinjung, T., & De Ridder, D. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70160-1 · Cited by 799
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Strand, D. S., Kim, D., & Peura, D. A. (2017) · Gut and Liver · doi:10.5009/gnl15502 · Cited by 671
Carey, I. M., Critchley, J. A., DeWilde, S., Harris, T., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc17-2131 · Cited by 604
Pharmacology of proton pump inhibitors
Shin, J. M., & Sachs, G. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0098-4 · Cited by 538
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Alexander, S. P. H., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14747 · Cited by 423
A unified approach to measuring the effect size between two groups using SAS
Yang, D., & Dalton, J. E. (2012) · Cited by 419
Kedika, R. R., Souza, R. F., & Spechler, S. J. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0951-9 · Cited by 324
Rybak, L. P., & Ramkumar, V. (2007) · Kidney International · doi:10.1038/sj.ki.5002434 · Cited by 298
Research works printed but not linked: 3
- World Health Organization, 2021, Deafness and hearing loss factsheet
- WHO Collaborating Centre for Drug Statistics Methodology, 2018, Defined daily doses
- UpToDate, 2021, Main causes of sudden sensorineural hearing loss
Cited by
Diabetes mellitus and hearing loss
Deng, Y., Chen, S., & Hu, J. P. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00737-z · Cited by 74
Kang, S.-W., An, M. H., Ha, S., Kim, M.-G., Park, T. J., Kim, H. K., Sheen, K., Park, R. W., & Park, S. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-81658-7 · Cited by 4
Proton pump inhibitors: Weighing the benefits and risks across various health conditions
Sizgoric, L., & Likić, R. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15960 · Cited by 4
Kim, S. Y., Yoo, D. M., Kwon, M. J., Kim, J. H., Kim, J., Lee, J. S., & Choi, H. G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610280 · Cited by 3
Proton pump inhibitors and risk of hearing loss; a systematic review
Khadivi, A., Amiri, F., Radnia, P., Salehi-pourmehr, H., Mirzaei Bavil, F., Pakkhesal, S., Hamzehzadeh, S., Moghaddam, Y. J., & Naseri, A. (2025) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-025-04241-5 · Cited by 2
Metadata
- Authors
- Yee, J., Han, H. W., & Gwak, H. S.
- Affiliations
- Ewha Womans University (KR)
- Corresponding author
- Gwak, Hye Sun
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2022-01-13
- Volume
- 88
- Issue
- 6
- Pages
- 2738-2746
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W4205497638
- Semantic Scholar
- 074584f8c5b03e7ebdfcc7b59fced7a016e42330
- Cited by
- 11
- References
- 44
- Citations by year
- 2025: 6 · 2024: 2 · 2023: 2 · 2022: 1
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- British Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- proton pump inhibitors, sensorineural hearing loss, tinnitus, type 2 diabetes, ototoxicity, drug safety, H2 receptor antagonists, gastroesophageal reflux disease, dose-response relationship
- MeSH terms
- Diabetes Mellitus, Type 2, Hospitals, Humans, Risk Factors, Tinnitus, Cohort Studies, Case-Control Studies, Hearing Loss, Proton Pump Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.